These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1568766)

  • 21. In vivo pharmacology of DuP 753.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):288S-298S. PubMed ID: 1854454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of DuP 753 on renal function of normotensive and spontaneously hypertensive rats.
    Fenoy FJ; Milicic I; Smith RD; Wong PC; Timmermans PB; Roman R
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):321S-326S. PubMed ID: 1854459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
    Cody RJ; Binkley PF; Haas GJ; Brown DM
    Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
    Brännström K; Morsing P; Arendshorst WJ
    Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydropyrimidine angiotensin II receptor antagonists.
    Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
    J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats.
    Oliveira DR; Santos RA; Santos GF; Khosla M; Campagnole-Santos MJ
    Hypertension; 1996 Jun; 27(6):1284-90. PubMed ID: 8641737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats.
    Touyz RM; Fareh J; Thibault G; Schiffrin EL
    Hypertension; 1996 Nov; 28(5):797-805. PubMed ID: 8901826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
    Nagura J; Yasuda S; Fujishima K; Yamamoto M; Hui C; Kawano K; Katano K; Ogino H; Hachisu M; Konno F
    Eur J Pharmacol; 1995 Feb; 274(1-3):201-11. PubMed ID: 7768273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Tani M; Haga H; Gomibuchi T; Sanada H; Fukuchi S
    Eur J Pharmacol; 1992 May; 215(2-3):305-8. PubMed ID: 1396995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
    Gorbea-Oppliger VJ; Fink GD
    J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
    Soltis EE
    J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An angiotensin system in the anterior hypothalamic area anterior is involved in the maintenance of hypertension in spontaneously hypertensive rats.
    Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
    Brain Res Bull; 2000 Jul; 52(4):291-6. PubMed ID: 10856827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL; Zhao X; Sun X; Hedner T
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
    Cox SL; Story DF; Ziogas J
    Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
    Schnecko A; Witte K; Lemmer B
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.
    Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
    Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.